Salute e Benessere

Insider information: BBS-Bioactive Bone Substitutes Plc appoints Juliusz…

BBS-Bioactive Bone Substitutes Plc, Company Announcement, Insider Information, 3 October 2023 at 4.00 p.m. (EET)Insider information: BBS-Bioactive Bone Substitutes Plc appoints Juliusz Rakowski as new CEO as BBS prepares for the commercial phase BBS-Bioactive Bone Substitutes Plc (“BBS” or "Company"), a publicly listed orthobiology company, today announced a strategic leadership transition, appointingJuliusz Rakowskias the new Chief Executive Officer (CEO), effective 3 November 2023...
Nasdaq GlobeNewswire
03/10/2023

Amolyt Pharma Announces Two Poster Presentations at the American Society for…

Details of the presentations are as follows: Title:Skeletal effects of hypoparathyroidism (HypoPT); data from the Canadian National Hypoparathyroidism Registry (CNHR)Format:Late Breaking Poster (Poster Session II) Date:Sunday, October 15, 2023 Session Time:1:30 – 3:00 p.m. PT (4:30 – 6:00 p.m. ET) Author/Presenter:Salma Hussein, M.D. (Clinical Fellow of Metabolic Bone Disease, McMaster University) Title:Eneboparatide, A Novel Investigational PTH1R Agonist, Maintains...
Nasdaq GlobeNewswire
03/10/2023

Unchained Labs makes waves in LNP formulation, launches the Sunny Suite!

Sunscreen helps researchers coast through LNP formulation, creating 96 unique, 200 µL – 2 mL LNP formulations in less than 6 hours. They simply load one plate with lipids, the other with payloads, choose their flow rates and Sunscreen takes it from there. Once they're done digging up the primo formulation with Sunscreen, researchers can pass the protocol over to Sunshine to tune in their LNP size and design a stellar process to scale them up from microliter to liters – using the same reusable…
PR Newswire
03/10/2023

Signant Health Launches Signant Biotech to Accelerate and Streamline Clinical…

Signant Biotech is anchored by a unified technology platform consisting of fully integrated EDC, eCOA, eConsent, RTSM, and telemedicine solutions. Delivered in conjunction with Signant's scientific and regulatory expertise, attentive project delivery teams who are well-versed in the needs of smaller sponsor organizations, as well as Signant's global operational reach, the technology platform and accompanying services enable customers to scale from local to multinational studies. Signant…
PR Newswire
03/10/2023

Menarini Silicon Biosystems announces new study results on use of CELLSEARCH®…

According to Dr.Anthony Lucci, MD, Professor of Surgery in the Department of Surgical Oncology at theUniversity of TexasMD Anderson Cancer Center:"In this study we were able to detect CTCs in over 75% of patients… at a median of nine months prior to a radiological relapse".This data suggests that a blood biomarker is now able to help assess which patients with melanoma are most at risk of experiencing a relapse."In the future these findings could lead to earlier intervention...
PR Newswire
03/10/2023

LEO Pharma Connects Affiliates with Veeva Vault Safety to Transform Safety…

"LEO Pharma is deeply committed to the safety of patients using its products," said Pilar Carrero, vice president of global safety at LEO Pharma. "With Veeva Vault Safety, we now have real-time visibility into adverse events and data transparency for affiliates that helps us work even better together." "LEO Pharma is deeply committed to the safety of patients using its products," saidPilar Carrero, vice president of global safety at LEO Pharma. "With Veeva…
PR Newswire
03/10/2023

Report on Spinal Muscular Atrophy (SMA) Disease : DLI's Extensive Disease…

The healthcare consulting services offered by Disease Landscape Insights has been expediting drug development efforts and streamlining the clinical trial management comprising of clinical trial feasibility analysis and clinical trial assessment for this debilitating condition. By comprehensively analyzing the prevalence, genetics, and clinical manifestations of SMA, these insights offer valuable data that researchers and pharmaceutical companies can leverage to identify potential drug targets…
PR Newswire
03/10/2023

Medtecs to Attend MEDICA 2023 and A+A 2023 Trade Fair in Germany and Showcase…

Founded in 1989, Medtecs has accumulated more than 30 years of professional manufacturing experience and currently supplies a comprehensive range of medical protection gears, products, and services worldwide, notably in the USA, Europe, and Asia Pacific. Medtecs operates the world's largest capacity in seam taping and boasts a robust manufacturing capacity of medical consumables and supplies, offering diverse product lines for every medical need and scenario. Medtecs has obtained various…
PR Newswire
03/10/2023

Investments Surge in Skin Cancer Market Amidst Promising Research Breakthroughs…

Skin Cancer- A looming threat: Skin Cancer- A looming threat: The alarming rise in the occurrence of this oncological disorder is a matter of global health concern. World Cancer Research Fund International through an epidemiology study has revealed that nearly 150,000 cases of skin cancer were reported in 2020. This increased disease burden has accelerated therapy and drug development activities across the globe. It is worth noting that in order to formulate effective treatment...
PR Newswire
03/10/2023

Innovations in Tonsillitis Disease Landscape Report: DLI's Extensive Disease…

With growing disease burden, the players operating in this vertical are trying their best to improve the overall tonsillitis management landscape. They are investing in R&D activities with an aim to introduce cutting edge diagnostic technologies and advanced treatment techniques. By leveraging DLI's healthcare consulting services, they are being equipped with complete knowledge on the regulatory guidelines and price reimbursement trends which in turn is enabling them to formulate ideal…
PR Newswire
03/10/2023

MINISO Opens its First UK "Blind Box" Store in Central London

During the Grand Opening, curious Londoners were welcomed by a lively party atmosphere, animated by the rhythmic beats of a live drummer. Families and children happily joined in the celebration, capturing joyful moments with MINISO's beloved mascot, PenPen. Customers also had the opportunity to claim a goody bag worth over £25 with any purchase, making it a memorable celebration for the store's inaugural day. During the Grand Opening, curious Londoners were welcomed by a lively party...
PR Newswire
03/10/2023

Nomination Committee appointed for Immunovia AB (Publ)

The Chair of the Board shall, as soon as reasonably practicable after the end of the third quarter, contact the three largest shareholders registered in the share register kept by Euroclear Sweden AB at this time in an appropriate manner and request them to, within a reasonable time, may not exceed 30 days, in writing to the Nomination Committee name the person the shareholder wishes to appoint as a member of the Nomination Committee. The Chair of the Board shall, as soon as reasonably...
PR Newswire
03/10/2023

Alvotech Enters into Exclusive Licensing Agreement with Kashiv BioSciences for…

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Kashiv Biosciences LLC (“Kashiv”), a fully integrated biopharmaceutical company, today announced that they have entered into an exclusive licensing agreement for AVT23 (also called ADL018), a proposed biosimilar to Xolair® (omalizumab), which is currently in clinical development.The agreement covers all 27 countries of the European Union, the...
Nasdaq GlobeNewswire
03/10/2023

Notice of Extraordinary General Meeting in Orexo AB (publ)

A shareholder who wishes to participate in the General Meeting must (i) be recorded as a shareholder in the share register maintained by Euroclear Sweden AB relating to the circumstances on 18 October 2023, and (ii) no later than 20 October 2023 give notice by post to Box 303, 751 05 Uppsala, Sweden, via e-mail to lena.wange@orexo.com, or by telephone +46 (0)018-780 88 00. When providing such notice, the shareholder shall state name, personal or corporate registration number, address…
PR Newswire
03/10/2023

Calliditas announces filing with UK MHRA for Kinpeygo in IgA nephropathy

The submission to the MHRA for full approval, made by STADA's affiliate Britannia Pharmaceuticals Ltd., is based on the full two-year data set from the Phase 3 NefIgArd clinical trial, as recently published in leading medical journal The Lancet [1]. The trial met its primary endpoint, with Kinpeygo demonstrating a highly statistically significant benefit over placebo (p value < 0.0001) in estimated glomerular filtration rate (eGFR) over the two-year period of nine months of treatment with…
PR Newswire
03/10/2023

The Oxford-Harrington Rare Disease Centre Launches Pioneering Therapeutics…

The Accelerator is a first-in-kind, transatlantic initiative to identify, fund and advance breakthrough academic discoveries to deliver new treatments for the 400 million people worldwide who suffer from rare diseases. Its goal is to deliver 40 new potentially life-changing therapies for rare diseases into clinical trials over the next ten years and target multiple approvals from regulators in key markets including the U.S., the U.K. and Europe. The Accelerator is a first-in-kind…
PR Newswire
03/10/2023

RevitaLash® Cosmetics Launches Global and Local Impact Initiative in the Fight…

RevitaLash® Cosmetics, renowned for its innovative lash, brow, and hair beautification products, has a heartfelt origin. It began with a gift from a husband, Dr. Michael Brinkenhoff, to his beloved wife during her battle with breast cancer. Today, the company remains committed to honoring the legacy of Dr. Brinkenhoff's late wife and RevitaLash® Cosmetics Co-Founder, Gayle Brinkenhoff. RevitaLash ®Cosmetics, renowned for its innovative lash, brow, and hair beautification products, has a...
PR Newswire
03/10/2023

STOPTOBER: Nearly 6 in 10 British Doctors Mistakenly Believe Nicotine Causes…

LONDON, Oct. 3, 2023 /PRNewswire/ -- Nearly 6 in 10 doctors in the UK mistakenly attribute negative health consequences of smoking to nicotine, directly jeopardising efforts made in helping smokers quit, a survey funded by a Foundation for a Smoke-Free World grant has found. LONDON,Oct. 3, 2023/PRNewswire/ -- Nearly 6 in 10 doctors in the UK mistakenly attribute negative health consequences of smoking to nicotine, directly jeopardising efforts made in helping smokers quit, a survey funded...
PR Newswire
03/10/2023

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures...
PR Newswire
03/10/2023

EAACI International Severe Asthma Forum (ISAF) Hybrid 2023: Advancing Severe…

Through cutting-edge research, interactive sessions, and meaningful collaborations, ISAF 2023 aspires to advance the severe asthma field and enhance the well-being of those affected by this condition. Through cutting-edge research, interactive sessions, and meaningful collaborations, ISAF 2023 aspires to advance the severe asthma field and enhance the well-being of those affected by this condition. The Organising Committee of ISAF Hybrid 2023 is excited to welcome participants to this...
PR Newswire
03/10/2023

WILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME…

"We are pleased to further expand our successful relationship with SUANFARMA, to bring sustainably sourced products to market by leveraging our joint capabilities and their proven efficient manufacturing resources," said Chris Savile, Willow's President & CEO. "Together, we see a number of opportunities to create alternative means to more sustainably produce key products for better human health and wellness and we look forward to working with the SUANFARMA team." "We…
PR Newswire
03/10/2023

Wex Photo Video launches programme to make photography available on prescription…

Research suggests that taking part in creative activities such as photography can help people suffering from depression, anxiety and even PTSD[2] by boosting self-esteem, reducing stress and combatting loneliness. Social prescribing can reduce the need for medical support and has been shown in some cases to reduce GP consultations by an average of 28% and A&E attendances by 24%[1]. Research suggests that taking part in creative activities such as photography can help people suffering from...
PR Newswire
03/10/2023

Press Release: Sanofi announces agreement for potential first-in-class vaccine…

Sanofi announcesagreementfor potential first-in-class vaccine against extraintestinal pathogenic E. coliExtraintestinal pathogenicE.coli(ExPEC) is a leading bacterial cause of sepsis, causing approximately 10 million cases of invasive ExPEC disease (IED) annually, worldwide 1,2 Phase 3 clinical trial of vaccine candidate ongoing. Novel ExPEC vaccine expected to complement existing older adult vaccine portfolioParis, October 3 , 2023. Sanofi announces today...
Nasdaq GlobeNewswire
03/10/2023

Press Release Biocartis Group NV: Disclosure of transparency notification

PRESS RELEASE: REGULATED INFORMATION 3 October 2023, 7:00 CEST Disclosure of transparency notificationMechelen, Belgium,3 October2023– Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular diagnostics company (Euronext Brussels: BCART), announces today, in accordance with Article 14, paragraph 1 of the Belgian Act of 2 May 2007 on the disclosure of major shareholdings in issuers of which...
Nasdaq GlobeNewswire
03/10/2023
Altri  Comunicati